Pharmaceutical compositions comprising (2S)-{(1S)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide

MDE20260005A1Pending Publication Date: 2026-01-31ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MDE20260005T
Authority / Receiving Office
MD · MD
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-03-01
Filing Date
2019-03-01
Publication Date
2026-01-31
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.